**Question:** True about malignant hyperthermia is all except

A. It is a respiratory disorder
B. It is caused by a defect in the central nervous system
C. It is associated with vitamin D deficiency
D. It is a disorder of calcium homeostasis

**Correct Answer:** .

**Core Concept:**
Malignant hyperthermia (MH) is a rare, potentially life-threatening pharmacological reaction that occurs primarily during anesthesia or muscle relaxation. It is a hypermetabolic state characterized by excessive release of calcium ions within the skeletal muscle cells leading to uncontrolled muscle contractions, heat production, and organ dysfunction.

**Why the Correct Answer is Right:**
Malignant hyperthermia is caused by a defect in the skeletal muscle ryanodine receptor (RYR1) gene, leading to an increased sensitivity to certain drugs like succinylcholine, halothane, and alfaxalone. This results in an abnormal calcium release from the sarcoplasmic reticulum into the muscle fibers, causing the characteristic hypermetabolic state.

**Why Each Wrong Option is Incorrect:**
A. Respiratory disorders are unrelated to malignant hyperthermia, which is a skeletal muscle issue.
B. MH is caused by a genetic mutation in the skeletal muscle ryanodine receptor (RYR1) gene, not related to the central nervous system.
C. MH is not associated with vitamin D deficiency, as it is a genetic disorder.
D. MH is primarily related to skeletal muscle dysfunction, not calcium homeostasis issues in the central nervous system.

**Clinical Pearl:**
In clinical practice, it is essential to be aware of triggers for malignant hyperthermia and avoid using these drugs in patients known to be susceptible to MH. It is crucial to have a high index of suspicion for MH in patients experiencing unexplained hyperthermia during anesthesia or muscle relaxation, as early recognition and management can significantly improve patient outcomes.